• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A型肉毒杆菌外毒素治疗多汗症。

Hyperhidrosis treated by botulinum A exotoxin.

作者信息

Odderson I R

机构信息

Department of Rehabilitation Medicine, University of Washington, Seattle, USA.

出版信息

Dermatol Surg. 1998 Nov;24(11):1237-41. doi: 10.1111/j.1524-4725.1998.tb04104.x.

DOI:10.1111/j.1524-4725.1998.tb04104.x
PMID:9834745
Abstract

BACKGROUND

Hyperhidrosis, or excessive sweating, can be emotionally challenging and socially and professionally disruptive, and there have been few effective treatments. Recently, botulinum toxin has been demonstrated to be an effective treatment for hyperhidrosis of the axillae and palms and for gustatory sweating.

OBJECTIVE

This article reviews the current treatments and outcomes achieved with chemodenervation of the eccrine sweat glands.

RESULTS

The antihydrotic response lasted 6-17 months for gustatory sweating, 2-8 months for axillary sweating, and 13 weeks to 12 months for palmar sweating.

CONCLUSIONS

Intracutaneous injections of botulinum toxin offer a simple, safe, and effective alternative to other conservative and surgical options.

摘要

背景

多汗症,即出汗过多,会在情绪上带来挑战,对社交和职业造成干扰,且有效治疗方法很少。最近,肉毒杆菌毒素已被证明是治疗腋窝和手掌多汗症以及味觉性出汗的有效方法。

目的

本文综述了目前通过对小汗腺进行化学去神经支配所取得的治疗方法和疗效。

结果

味觉性出汗的止汗反应持续6 - 17个月,腋窝出汗持续2 - 8个月,手掌出汗持续13周至12个月。

结论

皮内注射肉毒杆菌毒素为其他保守和手术治疗方案提供了一种简单、安全且有效的替代方法。

相似文献

1
Hyperhidrosis treated by botulinum A exotoxin.A型肉毒杆菌外毒素治疗多汗症。
Dermatol Surg. 1998 Nov;24(11):1237-41. doi: 10.1111/j.1524-4725.1998.tb04104.x.
2
Axillary hyperhidrosis: treatment with botulinum toxin A.腋窝多汗症:肉毒杆菌毒素A治疗
Arch Phys Med Rehabil. 1998 Mar;79(3):350-2. doi: 10.1016/s0003-9993(98)90020-x.
3
CT-Guided Chemical Thoracic Sympathectomy versus Botulinum Toxin Type A Injection for Palmar Hyperhidrosis.CT引导下化学性胸交感神经切除术与A型肉毒杆菌毒素注射治疗掌部多汗症的比较
Thorac Cardiovasc Surg. 2019 Aug;67(5):402-406. doi: 10.1055/s-0038-1668599. Epub 2018 Sep 14.
4
[Botulinum toxin in the treatment of focal hyperhidrosis].[肉毒杆菌毒素治疗局限性多汗症]
Wien Klin Wochenschr. 2001;113 Suppl 4:36-41.
5
Focal hyperhidrosis: effective treatment with intracutaneous botulinum toxin.
Arch Dermatol. 1998 Mar;134(3):301-4. doi: 10.1001/archderm.134.3.301.
6
No compensatory sweating after botulinum toxin treatment of palmar hyperhidrosis.肉毒杆菌毒素治疗手掌多汗症后无代偿性出汗。
Br J Dermatol. 2005 Feb;152(2):329-33. doi: 10.1111/j.1365-2133.2004.06255.x.
7
[Type A botulinum toxin: a new methods in treating focal hyperhidrosis. A summary of various possibilities in hyperhidrosis therapy with special emphasis type A botulinum toxin injections].[A型肉毒杆菌毒素:治疗局限性多汗症的新方法。多汗症治疗的各种可能性总结,特别强调A型肉毒杆菌毒素注射]
Praxis (Bern 1994). 2000 May 18;89(21):909-15.
8
Treatment of axillary hyperhidrosis by chemodenervation of sweat glands using botulinum toxin type A.使用A型肉毒杆菌毒素对汗腺进行化学去神经支配治疗腋窝多汗症。
J Drugs Dermatol. 2004 Nov-Dec;3(6):627-31.
9
Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients.A型肉毒杆菌毒素治疗局限性多汗症:61例患者的长期随访
Br J Dermatol. 2001 Aug;145(2):289-93. doi: 10.1046/j.1365-2133.2001.04349.x.
10
Subcutaneous curettage vs. injection of botulinum toxin A for treatment of axillary hyperhidrosis.皮下刮除术与注射A型肉毒杆菌毒素治疗腋窝多汗症的比较。
J Eur Acad Dermatol Venereol. 2001 May;15(3):207-11. doi: 10.1046/j.1468-3083.2001.00226.x.

引用本文的文献

1
Botulinum toxin the poison that heals: A brief review.肉毒杆菌毒素——治愈之毒:简要综述
Natl J Maxillofac Surg. 2016 Jan-Jun;7(1):10-16. doi: 10.4103/0975-5950.196133.
2
Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial.A型肉毒杆菌毒素治疗双侧原发性腋窝多汗症:随机、平行组、双盲、安慰剂对照试验。
BMJ. 2001 Sep 15;323(7313):596-9. doi: 10.1136/bmj.323.7313.596.